Evaluate the expected performance of Booking Holdings (BKNG) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Get a deeper insight into the potential performance of American Tower (AMT) for the quarter ended September 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Besides Wall Street's top-and-bottom-line estimates for UnitedHealth (UNH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.

NEW YORK , Oct. 23, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Firefly Aerospace Inc. ("Firefly" or the "Company") (NASDAQ: FLY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Company to Renew Focus on Expanding Annual Recurring Revenue Generation Company to Renew Focus on Expanding Annual Recurring Revenue Generation

Honeywell International Inc (NYSE:HON, ETR:ALD) on Thursday boosted its 2025 profit outlook as its third quarter financial results topped estimate, fueled by strong demand for its aerospace products. Honeywell's revenue for the quarter rose 7% year over year to $10.41 billion, surpassing the analyst consensus estimate of $10.14 billion, according to data compiled by LSEG.

Freeport-McMoRan (FCX) came out with quarterly earnings of $0.5 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.38 per share a year ago.

Cass Information Systems (CASS) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.21 per share a year ago.

Tesla (TSLA) shares fell Thursday morning after the company's quarterly profit came in short of analysts' estimates, even as it returned to revenue growth following two quarters of declines.

ARMOUR Residential REIT, Inc. (NYSE:ARR ) Q3 2025 Earnings Call October 23, 2025 8:00 AM EDT Company Participants Scott Ulm - CEO and Vice Chairman Gordon Harper - CFO & Secretary Sergey Losyev - Co-Chief Investment Officer Desmond Macauley - Co-Chief Investment Officer & Head of Risk Management Conference Call Participants Douglas Harter - UBS Investment Bank, Research Division Jason Weaver - JonesTrading Institutional Services, LLC, Research Division Trevor Cranston - Citizens JMP Securities, LLC, Research Division Timothy D'Agostino - B. Riley Securities, Inc., Research Division Eric Hagen - BTIG, LLC, Research Division Presentation Operator Good day, and welcome to …

In an era defined by a renewed great power competition and the dawn of autonomous warfare, the most compelling defense investments are shifting from traditional hardware manufacturers to the firms best positioned to dominate the technological arms race in artificial intelligence (AI), unmanned systems, and space. The defense sector has returned to the spotlight, driven by a strategic pivot toward technological superiority.

Cipher Mining (NASDAQ:CIFR) has surged 236% in 12 months, driven by Bitcoin gains and a strategic pivot to AI high-performance computing. Despite the AI HPC shift, CIFR remains highly dependent on Bitcoin, and its valuation appears stretched compared to peers with larger operations and treasuries. A $20 price target and Hold rating reflect concerns that the market has priced in too much premium too early, with better-valued alternatives available.

Viking Therapeutics, Inc. is a clinical-stage biotech focused on metabolic and endocrine therapies, highlighted by its promising VK2735 obesity drug. VKTX's pipeline includes late-stage GLP-1/GIP agonists and NASH treatments, positioning it as a key competitor to Eli Lilly and Novo Nordisk. Speculation of a takeover remains strong, with major pharma companies potentially interested due to VKTX's advanced pipeline and de-risking progress.

Fortinet is rated a Strong Buy, with a short-term price target of $88.53, and a medium-term upside of over 17%. FTNT benefits from growing recurring revenues, high margins, robust buybacks, and a $3.4B net cash position, supporting EPS growth and financial resilience. NATO's increased cybersecurity spending and FTNT's established relationship with the alliance present a significant addressable market opportunity.

Geron Corporation (GERN) is rated BUY due to strong early RYTELO sales, robust financials, and an undervalued stock price near 52-week lows. RYTELO, recently FDA-approved for lower-risk MDS, is driving revenue growth and has significant peak sales potential, with further pipeline expansion underway. A strengthened executive team and global expansion plans position GERN for sustainable growth, despite competition from established therapies like Reblozyl.

TXT's Q3 earnings topped estimates despite a revenue miss, led by strong Aviation and Bell segment growth.

VMI posts higher Q3 revenues and boosts full-year earnings outlook, driven by strong infrastructure demand despite agriculture softness.

United Bankshares (UBSI) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.82 per share. This compares to earnings of $0.7 per share a year ago.

Recently, Zacks.com users have been paying close attention to Progressive (PGR). This makes it worthwhile to examine what the stock has in store.

CyberArk (CYBR) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.